Literature DB >> 28525550

Long-term survival and quality of life after extracorporeal life support: a 10-year report.

Daniele Camboni1, Alois Philipp1, Verena Rottenkolber1, Matthaeus Zerdzitzki1, Andreas Holzamer1, Bernhard Floerchinger1, Dirk Lunz2, Thomas Mueller3, Christof Schmid1, Claudius Diez1.   

Abstract

OBJECTIVES: Information is lacking about long-term survival and quality of life (QOL) after treating patients on extracorporeal life support.
METHODS: Outcome data were assessed by phone interviews, a QOL analysis using the EuroQol 5-dimensions questionnaire and a retrospective inquiry of the Regensburg ECMO Registry database for the decade 2006-2015. A statistical analysis was obtained by comparing patients with a cardiosurgical intervention (CS = 189 patients) with those without (w/oCS = 307 patients).
RESULTS: Survival to discharge in the w/oCS group was higher than that in the CS group (w/oCS: 41.7% vs CS: 29.5%; P  = 0.004). A Kaplan-Meier analysis showed a significant difference between both groups in favour of patients w/oCS (log rank P  = 0.02). This difference was no longer statistically significant after propensity score matching ( P  = 0.07). The 1- and 2-year survival rates of discharged patients were 67% and 50% in the w/oCS group vs 60% and 45% in the CS group (log rank P  = 0.29). Eighty-two patients answered the QOL questionnaire after a mean follow-up time of 4.2 ± 2.9 years. A total of 75% could handle their daily life; 57% were not limited in their usual activities. Mobility impairment was noted in 50%; 25% returned to work or school. There were no differences in the EuroQol 5-dimension indices between the patient groups. However, compared to a normative age-matched population, significantly lower indices were calculated.
CONCLUSIONS: Long-term survival rates in patients requiring extracorporeal life support are acceptable with a probable advantage for patients without an operation and a narrowed QOL. The results are promising and encouraging, but there is also a need for improvement.
© The Author 2017. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.

Entities:  

Keywords:  Extracorporeal life support; Outcome; Quality-of-life

Mesh:

Year:  2017        PMID: 28525550     DOI: 10.1093/ejcts/ezx100

Source DB:  PubMed          Journal:  Eur J Cardiothorac Surg        ISSN: 1010-7940            Impact factor:   4.191


  7 in total

1.  To vent or not on veno-arterial extracorporeal membrane oxygenation, does it improve myocardial recovery and outcome?

Authors:  Daniele Camboni; Christof Schmid
Journal:  J Thorac Dis       Date:  2017-12       Impact factor: 2.895

2.  Cost-effectiveness in extracorporeal life support in critically ill adults in the Netherlands.

Authors:  Annemieke Oude Lansink-Hartgring; Dinis Dos Reis Miranda; Dirk W Donker; Jacinta J Maas; Thijs Delnoij; Marijn Kuijpers; Judith van den Brule; Erik Scholten; Hendrik Endeman; Alexander P J Vlaar; Walter M van den Bergh
Journal:  BMC Health Serv Res       Date:  2018-03-09       Impact factor: 2.655

3.  Health-related quality of life after extracorporeal membrane oxygenation: a single centre's experience.

Authors:  Marte Christine Ørbo; Sidsel Fredheim Karlsen; Ellinor Phillips Pedersen; Stig Eggen Hermansen; Per Bjørnerud Rønning; Kathrine Aas Nergaard; Torvind Naesheim; Truls Myrmel
Journal:  ESC Heart Fail       Date:  2019-05-07

4.  Incremental cost-effectiveness of extracorporeal membranous oxygenation as a bridge to cardiac transplant or left ventricular assist device placement in patients with refractory cardiogenic shock.

Authors:  Joseph Reza; Ashley Mila; Bradford Ledzian; Jingwei Sun; Scott Silvestry
Journal:  JTCVS Open       Date:  2022-07-02

5.  Neurological Complications of Veno-Arterial Extracorporeal Membrane Oxygenation: A Retrospective Case-Control Study.

Authors:  Yinan Luo; Qiao Gu; Xin Wen; Yiwei Li; Weihua Peng; Ying Zhu; Wei Hu; Shaosong Xi
Journal:  Front Med (Lausanne)       Date:  2021-07-01

6.  Long-term follow-up and quality of life in patients receiving extracorporeal membrane oxygenation for pulmonary embolism and cardiogenic shock.

Authors:  Tobias J Lange; Daniele Camboni; Andrea Stadlbauer; Alois Philipp; Sebastian Blecha; Matthias Lubnow; Dirk Lunz; Jing Li; Armando Terrazas; Christof Schmid
Journal:  Ann Intensive Care       Date:  2021-12-24       Impact factor: 6.925

7.  Long-Term Follow-Up of Survivors of Extracorporeal Life Support Therapy for Cardiogenic Shock: Are They Really Survivors?

Authors:  Rafal Berger; Attila Nemeth; Rodrigo Sandoval Boburg; Louise Vöhringer; Henning Florian Lausberg; Metesh Acharya; Christian Schlensak; Aron-Frederik Popov
Journal:  Medicina (Kaunas)       Date:  2022-03-15       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.